Studies of aryl phosph'/> Mixed Aryl Phosphonate Prodrugs of a Butyrophilin Ligand
首页> 外文期刊>ACS medicinal chemistry letters >Mixed Aryl Phosphonate Prodrugs of a Butyrophilin Ligand
【24h】

Mixed Aryl Phosphonate Prodrugs of a Butyrophilin Ligand

机译:丁霉素配体的混合芳基膦酸酯前药

获取原文
获取原文并翻译 | 示例
           

摘要

src="http://pubs.acs.org/appl/literatum/publisher/achs/journals/content/amclct/2017/amclct.2017.8.issue-9/acsmedchemlett.7b00245/20170908/images/medium/ml-2017-00245x_0003.gif">Studies of aryl phosphonate derivatives of a butyrophilin 3A1 ligand have resulted in identification of a potent stimulant of Vγ9 Vδ2 T cells. This compound, a mixed ester bearing one pivaloyloxymethyl substituent and one 1-naphthyl ester displayed an EC50 of 0.79 nM as a stimulant of T cell proliferation, and a 9.0 nM EC50 in an assay designed to measure interferon gamma production. In both assays, this is the most potent butyrophilin ligand prodrug yet reported, and thus it should be a valuable tool for studies of T cell function. Furthermore, mixed aryl/acyloxyalkyl esters may represent a new class of phosphonate prodrugs with high efficacy.
机译:src =“http://pubs.acs.org/appl/literatum/publisher/achs/journals/content/amclct/2017/amclct.2017.8.issue-9/acsmedchemlett.7b00245/20170908/70170908/images/medium/ml -2017-00245x_0003.gif“>酶磷酸芳基3a1配体的芳基膦酸酯衍生物的研究导致鉴定Vγ9Vδ2t细胞的有效兴奋剂。 该化合物,含有一种戊二酰氧基甲基取代基的混合酯和一个1-萘基酯的EC <亚萘基酯为0.79nm,作为T细胞增殖的兴奋剂,9.0nm EC 50 在旨在测量干扰素伽马生产的测定中。 在两种测定中,这是最有效的丁霉素配体前药尚未报道,因此应该是研究T细胞功能的有价值的工具。 此外,混合芳基/酰基氧基烷基酯可以代表具有高效力的新类膦酸酯前药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号